Sign Up to like & get
recommendations!
1
Published in 2022 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202203_28348
Abstract: This review focuses on the pharmacological and inhibition of the ovulation of progestin-only, estrogen-free contraceptive containing drospirenone in a dosage of 4 mg in a regimen 24/4. The USA and European regulatory authorities have approved…
read more here.
Keywords:
progestin;
inhibition ovulation;
pill intake;
drospirenone regimen ... See more keywords